Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Currency effects weighed on the Swiss drugmaker's first-quarter earnings
ORIGINAL SOURCE →via CNBC Top News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · CH
- [FINANCE] UBS AT1 Investors Get a Win as Swiss Plans Hold Off On Reform
- [NATURAL] Concert Pays Tribute to Swiss Fire Disaster Victims
- [FINANCE] Swiss central bank posts Q1 loss of 498 million Swiss francs - TradingView
- [FINANCE] Swiss central bank posts Q1 loss of 500 million Swiss francs - Reuters
- [CONFLICT] Roche First-Quarter Sales Drop, Hurt by Copycats and Currencies
- [CONFLICT] Nestle Sales of Snacks and Coffee Offset Formula Recall Impact